Utah Medical Products Stock Performance
| UTMD Stock | USD 64.57 0.39 0.61% |
The entity has a beta of 0.85, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Utah Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Utah Medical is expected to be smaller as well. At this point, Utah Medical Products has a negative expected return of -0.0758%. Please make sure to validate Utah Medical's potential upside, and the relationship between the total risk alpha and daily balance of power , to decide if Utah Medical Products performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Utah Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return 1.58 | Five Day Return (1.78) | Year To Date Return (21.43) | Ten Year Return 10.4 | All Time Return 6 K |
Forward Dividend Yield 0.019 | Payout Ratio 0.2806 | Last Split Factor 3:2 | Forward Dividend Rate 1.22 | Dividend Date 2024-10-04 |
1 | Disposition of 225 shares by Richins Paul O of Utah Medical at 69.72 subject to Rule 16b-3 | 08/29/2024 |
2 | Disposition of 1000 shares by Payne Barbara A of Utah Medical at 90.7 subject to Rule 16b-3 | 09/25/2024 |
| Utah Medical dividend paid on 4th of October 2024 | 10/04/2024 |
3 | Acquisition by Brian Koopman of 500 shares of Utah Medical at 74.64 subject to Rule 16b-3 | 10/17/2024 |
4 | Utah Medical Products GAAP EPS of 3.09, revenue of 31.74M | 10/29/2024 |
5 | Utah Medical Products Inc Reports Q3 2024 EPS of 1.025 Amid 20 percent Revenue Decline | 10/30/2024 |
6 | Acquisition by Brian Koopman of 500 shares of Utah Medical at 64.09 subject to Rule 16b-3 | 11/01/2024 |
7 | Utah Medical Products raises dividend by 1.75 to 0.305 | 11/05/2024 |
8 | With 66 percent institutional ownership, Utah Medical Products, Inc. is a favorite amongst the big guns | 11/07/2024 |
9 | Insider Trading | 11/12/2024 |
10 | FMR LLC Reduces Stake in Utah Medical Products Inc | 11/13/2024 |
| Begin Period Cash Flow | 75.1 M |
Utah |
Utah Medical Relative Risk vs. Return Landscape
If you would invest 6,802 in Utah Medical Products on August 24, 2024 and sell it today you would lose (345.00) from holding Utah Medical Products or give up 5.07% of portfolio value over 90 days. Utah Medical Products is currently does not generate positive expected returns and assumes 1.0653% risk (volatility on return distribution) over the 90 days horizon. In different words, 9% of stocks are less volatile than Utah, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Utah Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Utah Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Utah Medical Products, and traders can use it to determine the average amount a Utah Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0711
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | UTMD |
Estimated Market Risk
| 1.07 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Utah Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Utah Medical by adding Utah Medical to a well-diversified portfolio.
Utah Medical Fundamentals Growth
Utah Stock prices reflect investors' perceptions of the future prospects and financial health of Utah Medical, and Utah Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Utah Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0818 | ||||
| Profit Margin | 0.35 % | ||||
| Operating Margin | 0.38 % | ||||
| Current Valuation | 129.52 M | ||||
| Shares Outstanding | 3.39 M | ||||
| Price To Earning | 31.38 X | ||||
| Price To Book | 1.75 X | ||||
| Price To Sales | 4.97 X | ||||
| Revenue | 50.22 M | ||||
| Gross Profit | 32.2 M | ||||
| EBITDA | 24.8 M | ||||
| Net Income | 16.64 M | ||||
| Cash And Equivalents | 69.51 M | ||||
| Cash Per Share | 19.17 X | ||||
| Total Debt | 342 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 13.44 X | ||||
| Book Value Per Share | 36.10 X | ||||
| Cash Flow From Operations | 22.28 M | ||||
| Earnings Per Share | 4.28 X | ||||
| Market Capitalization | 219 M | ||||
| Total Asset | 135.46 M | ||||
| Retained Earnings | 138.34 M | ||||
| Working Capital | 101.56 M | ||||
| Current Asset | 32.87 M | ||||
| Current Liabilities | 4.07 M | ||||
About Utah Medical Performance
By analyzing Utah Medical's fundamental ratios, stakeholders can gain valuable insights into Utah Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Utah Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Utah Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 173.26 | 181.92 | |
| Return On Tangible Assets | 0.14 | 0.28 | |
| Return On Capital Employed | 0.13 | 0.12 | |
| Return On Assets | 0.12 | 0.21 | |
| Return On Equity | 0.13 | 0.12 |
Things to note about Utah Medical Products performance evaluation
Checking the ongoing alerts about Utah Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Utah Medical Products help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Utah Medical generated a negative expected return over the last 90 days | |
| About 74.0% of the company outstanding shares are owned by institutional investors | |
| On 4th of October 2024 Utah Medical paid $ 0.3 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Insider Trading |
- Analyzing Utah Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Utah Medical's stock is overvalued or undervalued compared to its peers.
- Examining Utah Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Utah Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Utah Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Utah Medical's stock. These opinions can provide insight into Utah Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |